Connect with us

Hi, what are you looking for?

Top Stories

Editor's Pick

Pfizer expects updated COVID-19 vaccine data for kids under 5 by April

NEW YORK – Pfizer Inc expects the latest results from a clinical trial for kids under the age of 5 of the COVID–19 vaccine it developed with Germany’s BioNTech SE by April, a top company scientist said on Wednesday.

“The study has been amended to give a third dose to everybody who’s less than five at least eight weeks after their last vaccination,” Dr. Alejandra Gurtman, a Pfizer vaccine researcher said at a meeting of the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). She said the company aims to have data for the age group by the end of March or the beginning of April.

In December, Pfizer said it was changing the design of the trial because children between the ages of 2 and 4 who were given two 3-microgram doses of the vaccine did not have the same immune response that a larger dose of the vaccine generated in older children.

Gurtman also said the company was studying a third dose of its vaccine in children ages 5 to 11, six months after their second dose.

The Pfizer-BioNTech vaccine is authorized in the United States for people age 5 and older. On Wednesday, ACIP backed booster shots of the vaccine for ages 12 to 15. – Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Editor's Pick

The Board of Investments (BoI) has cleared Sinoma Energy Conservation (Cebu) Waste Heat Recovery Co. Inc. to serve as the operator of a 4.5-megawatt...

Editor's Pick

The world’s food-import bill is set to jump even more than expected to a record this year, increasing the threat of hunger, especially in...

Editor's Pick

Century Properties Group, Inc. has approved a P6-billion debt securities program, of which half of the amount will make up the first tranche including...

Editor's Pick

MORE FILIPINOS should become entrepreneurs to allow economic and technological progress amid the ongoing coronavirus disease 2019 (COVID-19) pandemic. Vince Dominic Yamat, managing director...

Disclaimer: SecretsOfRichDads.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 Secrets Of Richdads. All Rights Reserved.